Aim Hyperphosphataemia is associated with increased mortality and morbidity in end stage renal disease. Despite phosphate binder therapy, a large proportion of patients do not reach the treatment target. In five contemporary binders we explored the influence of pH and phosphate concentration on phosphate binding. This interaction could be of relevance in clinical practice. Methods Phosphate binding was quantified in vitro in 25 mL of purified water containing phosphate concentrations of 10, 15 and 20 mM and baseline pH values of 3.0 or 6.0, with a binder over 6 h. Lanthanum carbonate, calcium acetate/magnesium carbonate, sevelamer carbonate, calcium carbonate and sucroferric oxyhydroxide, 67 mg of each, were used. The experiments were perfo...
Phosphate levels are strikingly associated with poor outcomes in chronic kidney disease (CKD) and en...
Calcium acetate is used as an oral phosphate binder to control hyperphosphatemia in patients with ch...
Magnesium carbonate as a phosphorus binder: A prospective, controlled, crossover study. The use of c...
Aim Hyperphosphataemia is associated with increased mortality and morbidity in end stage renal disea...
A comparison of clinically useful phosphorus binders for patients with chronic kidney failure. Over ...
An introduction to phosphate binders for the treatment of hyperphosphatemia in patients with chronic...
Several studies have evidenced the association between high serum phosphorus concentrations and adve...
Hyperphosphataemia in patients with chronic kidney disease, particularly those on dialysis, can be a...
Hyperphosphatemia is an inevitable consequence of end-stage chronic kidney disease and is present in...
Objective: Hyperphosphatemia in end-stage renal disease (ESRD) is associated with many serious patie...
BACKGROUND: Phosphate binders' constituents have alkalotic or acidotic properties and may contribute...
Phosphate binder therapy for attainment of K/DOQI™ bone metabolism guidelines. Hyperphosphatemia in ...
Calcium acetate, an effective phosphorus binder in patients with renal failure. Calcium salts are in...
Valeria Cernaro, Domenico Santoro, Antonio Lacquaniti, Giuseppe Costantino, Luca Visconti, Antoine B...
Hyperphosphatemia has an important role in the development of secondary hyperparathyroidism and bone...
Phosphate levels are strikingly associated with poor outcomes in chronic kidney disease (CKD) and en...
Calcium acetate is used as an oral phosphate binder to control hyperphosphatemia in patients with ch...
Magnesium carbonate as a phosphorus binder: A prospective, controlled, crossover study. The use of c...
Aim Hyperphosphataemia is associated with increased mortality and morbidity in end stage renal disea...
A comparison of clinically useful phosphorus binders for patients with chronic kidney failure. Over ...
An introduction to phosphate binders for the treatment of hyperphosphatemia in patients with chronic...
Several studies have evidenced the association between high serum phosphorus concentrations and adve...
Hyperphosphataemia in patients with chronic kidney disease, particularly those on dialysis, can be a...
Hyperphosphatemia is an inevitable consequence of end-stage chronic kidney disease and is present in...
Objective: Hyperphosphatemia in end-stage renal disease (ESRD) is associated with many serious patie...
BACKGROUND: Phosphate binders' constituents have alkalotic or acidotic properties and may contribute...
Phosphate binder therapy for attainment of K/DOQI™ bone metabolism guidelines. Hyperphosphatemia in ...
Calcium acetate, an effective phosphorus binder in patients with renal failure. Calcium salts are in...
Valeria Cernaro, Domenico Santoro, Antonio Lacquaniti, Giuseppe Costantino, Luca Visconti, Antoine B...
Hyperphosphatemia has an important role in the development of secondary hyperparathyroidism and bone...
Phosphate levels are strikingly associated with poor outcomes in chronic kidney disease (CKD) and en...
Calcium acetate is used as an oral phosphate binder to control hyperphosphatemia in patients with ch...
Magnesium carbonate as a phosphorus binder: A prospective, controlled, crossover study. The use of c...